Japan’s 2026 Medical Robotics Market: Current State, Trends, Growth Potential, and Key Companies

Japan’s 2026 Medical Robotics Market: Current State, Trends, Growth Potential, and Key Companies

Driven by a rapidly aging population, a shortage of healthcare professionals, and strong demand for medical digital transformation (DX), Japan’s medical robotics market is growing rapidly.

Technological innovation in healthcare continues to accelerate, with developments ranging from surgical support robots to rehabilitation and caregiving robots, as well as AI-integrated diagnostic support systems.

This article provides a comprehensive overview of Japan’s medical robotics market, covering its current size and state, key growth drivers, the latest trends, leading companies, and the future outlook.

What Is Japan’s Medical Technology Market? Key Basics Explained

Below outlines the essential foundational knowledge to understand Japan’s medical technology market.

Understanding Medical Technology in Healthcare

Medical technology refers to products, services, and systems that use technology in the medical and healthcare fields to improve the quality and efficiency of diagnosis, treatment, prevention, and care.

Often referred to as “MedTech” or “HealthTech,” it encompasses a broad range of areas—from medical devices and electronic health records to AI-based imaging diagnostics and wearable devices.

In recent years, advances in digital technology, AI, robotics, and IoT have significantly expanded its scope. Since the 2020s in particular, the COVID-19 pandemic has accelerated medical DX, leading to increased global attention and investment in medical technology.

In Japan, the Ministry of Health, Labor and Welfare and the Ministry of Economy, Trade and Industry are also promoting medical technology through policy support. At the same time, domestic startups and major manufacturing companies continue to enter the field and invest in it.

Differences Between MedTech and HealthTech

Although MedTech and HealthTech are often used interchangeably, they differ in the following ways:

Overview

• MedTech: Primarily refers to technologies, systems, and services directly related to medical devices, diagnosis, and treatment
• HealthTech: Covers a broader range of health management, prevention, and wellness

Scope

• MedTech: Includes products used directly by physicians in clinical practice, such as surgical robots, medical imaging equipment (MRI, CT, etc.), in vitro diagnostics, pacemakers, and endoscopic systems
• HealthTech: Includes smartphone-based health management apps, wearable devices for biometric monitoring, online medical platforms, and medical information management systems (electronic health records, PHR, etc.)

Quality and Standards

• MedTech: Often requires approval and certification from regulatory authorities and must meet high safety and quality standards
• HealthTech: Includes many consumer-oriented products and numerous services that are not subject to medical device regulations

Medical robots are a representative example of MedTech. At the same time, robots that support patients’ daily health management and caregiving also overlap with the HealthTech domain. Therefore, understanding medical technology as a whole requires a comprehensive perspective that encompasses both concepts.

Current State and Market Size of Japan’s Medical Robotics Market

The following section explains the current state and size of Japan’s medical robotics market.

What Are Medical Robots? Main Types and Applications

Medical robots are robotic systems that support or autonomously perform tasks such as diagnosis, treatment, rehabilitation, caregiving, and logistics in medical and healthcare settings. Their applications are wide-ranging and include the following:

• Surgical support robots (precisely replicate surgeons’ hand movements)
• Dispensing support robots (assist pharmacists with drug selection, weighing, dispensing, and packaging)
• Rehabilitation support robots (support functional recovery after stroke and orthopedic rehabilitation)
• Nursing care and daily living support robots (assist with transfers, bathing, and toileting for elderly individuals)
• Logistics and transport robots (transport medications and specimens within hospitals)
• Diagnostic support robots (assist with examinations such as endoscopy and ultrasound)
• Disinfection and sterilization robots (help prevent hospital-acquired infections)
• Monitoring and medication support robots (assist elderly individuals and patients with chronic conditions in managing medication)

The Role of Medical Robots in the Medical Technology Market

Within the broader medical technology market, medical robots represent a segment characterized by high added value and strong growth rates. Alongside the overall medical device market and software-based areas such as AI-driven diagnostic support and electronic health records/PHR, they are gaining attention as an advanced product category that integrates both hardware and software.

One reason medical robots are viewed as distinct within the medical technology market is their technological complexity. They combine robotics, sensor technology, AI, communications technology, and medical expertise, requiring multidisciplinary knowledge and significant investment for development, manufacturing, and operation. As a result, barriers to entry are high, and once established, these products tend to maintain strong competitive advantages.

In Japan, the government is also strategically promoting the development and adoption of medical robots. Under national initiatives such as the “Robot New Strategy” and the “Healthcare and Medical Strategy,” efforts are underway to build an ecosystem through collaboration among industry, academia, and government.

Japan’s Position in the Global Medical Robotics Market

Japan holds a strong but secondary position globally in the medical robotics market. While the United States leads—driven by companies like Intuitive Surgical—Japan remains one of the most advanced markets in the Asia-Pacific region, alongside China.

A key strength is Japan’s expertise in precision manufacturing and robotics, built on decades of leadership in industrial automation. Such a foundation supports the development of high-quality medical devices and robotic systems, particularly in surgical tools and rehabilitation technologies.

At the same time, Japan has historically relied on foreign systems, especially the da Vinci surgical robot, which has dominated the market. In response, domestic companies are increasingly developing their own platforms to improve competitiveness and reduce dependence on international technologies.

Regionally, Japan plays an important role in driving innovation and adoption in the Asia-Pacific, supported by its advanced healthcare system and rapidly aging population.

Market Size and Growth Trends of Medical Robots

As of 2025, Japan’s domestic medical robotics market has reached USD 2,882.0 million, with surgical support, rehabilitation, and nursing care robots driving growth.

Globally, the market was valued at USD 18.98 billion in 2025 and is projected to expand at a compound annual growth rate (CAGR) of 16.33% from 2025 to 2034.

As we have seen, Japan is positioned as a major market in the Asia-Pacific region alongside China. With its advanced healthcare infrastructure and strong technological development capabilities, it has significant growth potential.

In the nursing care robotics sector, the Ministry of Health, Labor and Welfare, and the Ministry of Economy, Trade and Industry are jointly developing subsidy programs and certification systems to help reduce adoption costs for facilities. For surgical support robots, several domestically developed systems have received regulatory approval, and their adoption in Japan is expected to expand.

Three Key Factors Driving Growth in Japan’s Medical Robotics Market

The following section explains three key factors behind the growth of Japan’s medical robotics market.

1. Aging Population and Expanding Healthcare Demand

Japan is one of the most rapidly aging societies in the world, with an aging rate of 29.3% as of 2024. Following the “2025 problem,” in which the baby boomer generation enters the late-stage elderly category (age 75 and over), demand for medical and nursing care services is increasing rapidly.

The growth in the elderly population means an increase in patients requiring long-term care, including those with chronic diseases, lifestyle-related illnesses, dementia, and musculoskeletal disorders. The aging population has led to a need for stronger healthcare and caregiving infrastructure, including increased surgical volumes, greater demand for rehabilitation services, and expanded care facilities. As a result, demand for efficiency and automation through robotics continues to rise.

2. Shortage of Healthcare Workers and Rising Demand for Efficiency

Japan is facing a serious shortage of healthcare professionals, including physicians, nurses, and caregivers, particularly in rural areas, where maintaining healthcare services itself is becoming increasingly difficult.

Medical robots are gaining attention as one solution to the labor shortage. The use of surgical support robots can improve per-surgeon surgical efficiency, enabling the treatment of more patients.

In addition, the introduction of transport and medication-delivery robots can reduce the workload of nurses and pharmacists.

Furthermore, with the enforcement of regulations on physicians’ overtime work starting in April 2024, healthcare institutions now view operational efficiency as an urgent priority, further accelerating the adoption of robotics and automation technologies.

3. Acceleration of Medical Technology and Medical DX

Japan’s healthcare sector has long been considered slow in adopting digitalization, but in recent years, medical DX has accelerated. As electronic health records become more widespread, medical information sharing using My Number cards expands, and online healthcare services grow, the digitalization and sharing of medical data are advancing. At the same time, integration between medical robots and information systems is deepening.

Advances in AI and 5G communication technologies are also dramatically enhancing the capabilities and applications of medical robots. AI-equipped surgical robots can analyze real-time data during procedures to support physicians’ decision-making, improving both safety and precision. Remote surgical support using 5G is also becoming a reality, opening up new possibilities for delivering healthcare beyond geographical constraints.

Government policy support is another key driver of market growth. Initiatives such as the “Development and Standardization of Robotic Care Equipment” project led by the Ministry of Economy, Trade and Industry, the Ministry of Health, Labor and Welfare, and the Ministry of Education, Culture, Sports, Science and Technology, as well as support for healthcare initiatives under the Cabinet Office’s Strategic Innovation Promotion Program (SIP), are fostering collaboration between the public and private sectors and supporting the expansion of the medical robotics market.

2026 Trends in Medical Robots in Japan

This section provides an overview of medical robot trends in Japan as of 2026.

Advancements and Wider Adoption of Surgical Support Robots

One of the most notable trends in 2026 is the advancement of surgical support robots and the growing adoption of domestically developed systems. Until recently, Intuitive Surgical’s da Vinci dominated the domestic market with an overwhelming share. However, in recent years, Japanese-made surgical support robots have obtained regulatory approval and have begun entering the market in earnest.

Hinotori, developed by Medicaroid Corporation, received regulatory approval in 2020 as Japan’s first domestically produced surgical support robot. As of 2026, it is being used in actual surgical procedures at multiple medical institutions across Japan.

In addition, the range of applicable procedures is expanding. While usage has traditionally been concentrated in fields such as urology, gynecology, and gastrointestinal surgery, it is expected to broaden to include thoracic surgery, orthopedic surgery, ophthalmology, and other specialties.

Expansion of Rehabilitation and Nursing Care Robots

In the fields of rehabilitation support robots and nursing care robots, 2026 marks a phase of expanding practical use and adoption.

A leading example of a rehabilitation robot is HAL (Hybrid Assistive Limb), developed by CYBERDYNE. The wearable robot supports functional improvement in patients with neurological and muscular impairments. Its track record of use within Japan continues to grow, alongside ongoing international expansion.

In the nursing care sector, a wide variety of robots—including transfer support, communication, monitoring, and excretion support robots—are being introduced into care facilities and home care settings.

Government subsidy programs that help reduce implementation costs are also driving adoption. As of 2026, the rate of robot adoption in care facilities has increased significantly compared to previous years.

At the same time, rehabilitation and nursing care robots are increasingly being integrated with digital technologies. These systems are evolving beyond standalone robots, incorporating IoT sensors to monitor patient and user conditions, AI to generate personalized rehabilitation programs, and cloud-based data sharing to enable collaboration across multiple professions.

Advancing Medical Technology Through AI Integration

As of 2026, the integration of AI and medical robots has reached a significantly more advanced stage than before. Of particular interest is the fusion of medical AI—leveraging large language models (LLMs) and foundation models—with physical robotic systems.

In surgical support, AI systems that analyze intraoperative images in real time and visually present tumor locations and critical blood vessel pathways to surgeons are now in practical use. In medical imaging diagnostics, AI has greatly improved radiologists' accuracy and efficiency, contributing to higher rates of early cancer detection.

In addition, systems that integrate diagnostic-support AI with electronic medical records and test data continue to evolve. These systems enable “predictive medicine,” which forecasts changes in patient conditions in real time and issues alerts. When integrated with robots, they provide consistent support across the entire process—from diagnosis to treatment and postoperative management.

Furthermore, AI-integrated robots designed to reduce the workload of physicians and nurses—such as voice-input electronic medical records using natural language processing (NLP) and AI assistant robots that interact with patients—are expected to be introduced in many hospitals by 2026.

Growth and Development of Telemedicine and Robotic Medicine

The integration of telemedicine and medical robots is one of the most important trends in Japan’s medical technology landscape in 2026. As 5G infrastructure continues to expand and high-speed, low-latency networks become more widespread, the practical implementation of remote surgical support and remote diagnostic support robots is accelerating.

Pilot programs and research are already underway at several university hospitals and research institutions across Japan, and efforts toward full-scale implementation are intensifying.

The spread of online medical consultations is also promoting collaboration with medical robots, including robots that assist with at-home examinations and systems that enable real-time sharing of patient information and imaging data between medical institutions. The integration of telemedicine and medical robots is taking shape in various forms.

Increasing Investment and Startup Activity in Medical Robotics

Investment and startup activity in Japan’s medical robotics sector has been steadily expanding, reflecting broader growth in the country’s MedTech ecosystem. Japan is seeing a rise in medical device and robotics startups, supported by venture capital, accelerators, and government-backed initiatives focused on healthcare innovation.

University spin-offs play a defining role in the rise of medical device and robotics startups. For example, Riverfield Inc. originated from the Tokyo Institute of Technology and Tokyo Medical and Dental University, demonstrating how academic research is translated into commercial medical robotics solutions.

At the same time, collaboration between academia, hospitals, and industry is strengthening, particularly in innovation hubs such as Osaka, where research, clinical needs, and commercialization efforts are closely aligned.Overall, these trends are accelerating innovation and making Japan an increasingly dynamic market for medical robotics.

Japanese Medical Robot and Medical Technology Companies to Watch in 2026

Below introduces several Japanese companies in the medical robot and medical technology sectors to watch in 2026.

Leading Companies in the Medical Robot Sector

The following two companies represent the medical robot field:

Medicaroid Corporation

Medicaroid Corporation was established through a joint investment by Kawasaki Heavy Industries and Sysmex. Its Hinotori Surgical Robot System received regulatory approval in 2020 as Japan’s first domestically produced surgical support robot.

Hinotori is characterized by its compact arm design and high level of operability. It has been optimized for Japanese operating room environments, with a strong emphasis on ergonomics that allows surgeons to operate in a natural posture.

As of 2026, the number of medical institutions adopting hinotori continues to grow, with increasing use particularly in urology. Going forward, the company plans to expand the range of supported procedures and strengthen integration with AI, while pursuing both domestic market share growth and international expansion.

Riverfield Inc.

Riverfield Inc. was established in 2014 as a venture originating from Tokyo Institute of Technology and Tokyo Medical and Dental University. The company is developing surgical support robots based on proprietary technology that utilizes pneumatic pressure. Its key technological features include soft, flexible movement enabled by “pneumatic control” and highly precise haptic feedback.

While most surgical support robots rely on motor-driven systems, Riverfield’s approach uses pneumatic pressure to more naturally replicate the delicate force required when interacting with biological tissues. Such technology is expected to allow surgeons to operate the robot with a sensation similar to using their own hands.

Companies to Watch in the Medical Technology Sector

The following two companies are notable in the medical technology field:

AI Medical Service Inc.

AI Medical Service Inc. develops medical AI systems that analyze endoscopic images to detect lesions, including early-stage cancer. During endoscopic procedures, the system analyzes images in real time, identifies subtle lesions that are easily overlooked, and presents them to physicians. Such technology has strong potential to improve early detection rates for gastrointestinal cancers.

The company’s technology is based on deep learning models trained on large volumes of endoscopic image data and achieves diagnostic accuracy comparable to that of specialists.

Ubie Inc.

Ubie Inc. is a medical technology company that provides Ubie AI Symptom Checker, an AI-based medical interview and diagnostic support system. Patients enter their symptoms on a smartphone or tablet before their visit, and the AI conducts an appropriate medical interview and organizes and presents the information to physicians.

The system significantly reduces the time required for patient interviews, allowing physicians to focus more on examinations. As of 2026, it has been introduced in thousands of medical institutions nationwide and is contributing substantially to improved efficiency in healthcare settings.

In addition to AI-based interviews, Ubie offers services such as symptom search engines and is strengthening its presence as a new platform that connects patients and medical institutions.

Three Challenges in Japan’s Medical Robot Market

This section outlines three key challenges facing Japan’s medical robot market.

1. High Implementation Costs and Cost-Effectiveness Issues

One of the biggest challenges is the high cost of implementation. Surgical support robots can cost several hundred million yen for the main unit alone, and additional expenses such as annual maintenance, consumables, and specialized instruments must also be considered.

Insurance coverage is another issue. While some procedures using surgical support robots are covered, the range is limited, and when procedures are not covered, patients inevitably face higher out-of-pocket costs.

For nursing care robots as well, although subsidy programs exist, the actual implementation costs remain a significant burden for facilities.

2. Operational Burden and Workforce Shortages

Even when medical robots are introduced, they are ineffective without personnel with the specialized knowledge and skills required to operate them properly. Japan faces a shortage of such personnel, and surgeons must undergo specialized training programs to acquire the skills needed to operate surgical support robots.

Securing engineers and technicians responsible for routine maintenance and troubleshooting is also a major challenge, especially for regional medical institutions, where access to specialized technical support is limited, sometimes making stable operation after implementation difficult.

3. Regulatory and Approval Barriers and Delayed Adoption

Japan’s regulatory approval process for medical devices strictly evaluates safety and effectiveness. However, compared to other countries, review periods can be longer, an issue long referred to as the “drug and device lag.”

As a result, while innovative medical robots are adopted earlier globally, approval delays in Japan can postpone the benefits reaching patients.

In recent years, efforts by the PMDA (Pharmaceuticals and Medical Devices Agency) have improved the efficiency and speed of reviews. However, establishing evaluation standards for AI-equipped medical devices and innovative products that do not fit existing frameworks remains a significant challenge.

Future Outlook for Japan’s Medical Robot Market

The following section discusses the future outlook for Japan’s medical robot market.

Collaboration with International Companies and Market Globalization

Looking ahead, collaboration with international companies and continued market globalization are expected to accelerate in Japan’s medical robotics sector. Major global players from the United States, Europe, and China—including Intuitive Surgical, Medtronic, and Siemens Healthineers—are strengthening their presence in Japan, one of the world’s largest and most advanced healthcare markets. As a result, competition between foreign and domestic companies is intensifying.

At the same time, expanding into overseas markets has become a key growth strategy for Japanese companies. Japan’s strengths in robotics, precision manufacturing, and materials science are highly regarded globally, offering strong potential to compete internationally in medical robotics.

Demand for medical robots is also rising rapidly across Asia, driven by aging populations and improving healthcare infrastructure. For Japanese companies, the geographically and culturally close Asian market represents an attractive opportunity, with expansion through partnerships with local companies and medical institutions seen as a particularly promising approach.

These dynamics are influencing pricing, innovation, and adoption. Increased competition is driving technological advancement—such as AI integration and enhanced surgical capabilities—while also helping address barriers like cost and usability. As more global and domestic players enter the market, the availability and accessibility of robotic-assisted procedures in Japan are expected to continue expanding.

Potential for Market Expansion Through Technological Advancements

The rapid evolution of AI, innovations in robotics, and the widespread adoption of IoT, 5G, and cloud computing are expected to converge, significantly expanding the functionality and scope of applications for medical robots.

With advances in large language models and foundation models, medical robots are expected to develop sophisticated capabilities, such as interacting with healthcare professionals in natural language and integrating complex medical information to support decision-making.

Advances in nanotechnology may also transform the future of medical robots. The realization of “in-body robots”—micro- and nano-scale robots capable of transporting and releasing drugs within the body or performing localized treatments—holds the potential to revolutionize cancer treatment and endovascular therapy.

Conclusion: Japan’s Medical Robot Market Is a Growing Sector

This article has outlined the current state and size of Japan’s medical robot market, the factors behind its growth, the latest trends for 2026, notable companies, key challenges, and future outlook.

With the combined impact of an aging society, a shortage of healthcare workers, and the acceleration of healthcare digital transformation (DX), Japan’s medical robot market is on a steady growth trajectory. Key trends—such as the advancement and localization of surgical support robots, the expansion of rehabilitation and nursing care robot applications, the advancement of medical technology through AI integration, and the integration with telemedicine—are further driving market expansion.

At the same time, challenges such as high implementation costs, workforce shortages, and regulatory and approval issues remain. Addressing these challenges will require collaboration among industry, academia, and government to advance cost-reduction technologies, strengthen human resource development and training systems, and continue updating regulatory frameworks.